Lincoln Pharmaceuticals (BOM:531633) Marketable Securities : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Lincoln Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Lincoln Pharmaceuticals's Marketable Securities for the quarter that ended in Dec. 2023 was ₹0 Mil.

Lincoln Pharmaceuticals's annual Marketable Securities increased from Mar. 2021 (₹807 Mil) to Mar. 2022 (₹1,082 Mil) and increased from Mar. 2022 (₹1,082 Mil) to Mar. 2023 (₹1,213 Mil).

Lincoln Pharmaceuticals Marketable Securities Historical Data

The historical data trend for Lincoln Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lincoln Pharmaceuticals Marketable Securities Chart

Lincoln Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Marketable Securities

Get a 7-Day Free Trial

342.41

806.72

1,081.95

1,212.72

Lincoln Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															-	1,212.72	-	1,603.00	-

Lincoln Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Lincoln Pharmaceuticals (BOM:531633) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Lincoln Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Lincoln Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lincoln Pharmaceuticals (BOM:531633) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lincoln Pharmaceuticals Ltd (BOM:531633) » Definitions » Marketable Securities

Traded in Other Exchanges

LINCOLN:India

Address

Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060

Website

https://www.lincolnpharma.com

Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of Cardiac, Diabetic, Anti-malarial, Anti-biotic, Anti-fungal, Cephalosporin, Analgesic, Anaesthetics, Anti-pyretic, GIT products, Vitamin-Minerals, and Iron preparations. Geographically, the company carries out sales in India and outside India; generating key revenue from outside India.

Lincoln Pharmaceuticals (BOM:531633) Headlines

No Headlines